20.01.2017 Views

Waikato Business News January/February 2017

Waikato Business News has for a quarter of a century been the voice of the region’s business community, a business community with a very real commitment to innovation and an ethos of co-operation.

Waikato Business News has for a quarter of a century been the
voice of the region’s business community, a business community
with a very real commitment to innovation and an ethos of
co-operation.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

16 WAIKATO BUSINESS NEWS <strong>January</strong>/<strong>February</strong> <strong>2017</strong><br />

<strong>Waikato</strong> companies<br />

attract significant<br />

angel funding<br />

Two <strong>Waikato</strong> companies are benefiting from<br />

Bay of Plenty-based investment facilitator<br />

Enterprise Angels’ growing presence in<br />

<strong>Waikato</strong>.<br />

Ruakura-based companies<br />

Quantec and Synthase<br />

Biotech have together<br />

raised more than $1 million,<br />

bringing the total number of<br />

<strong>Waikato</strong> companies that have<br />

been funded by Enterprise<br />

Angels to five.<br />

Both companies received<br />

strong interest when they<br />

listed on the newly launched<br />

AngelEquity platform.<br />

AngelEquity’s goal is to offer<br />

wholesale investors the opportu-<br />

nity to invest in New Zealand’s<br />

early-stage, angel-backed companies<br />

anytime, anywhere.<br />

Agri-tech company Quantec<br />

raised a total of $429,000 - well<br />

above the targeted $320,000.<br />

The Government’s Seed<br />

Co-Investment Fund (SCIF)<br />

committed a further $100,000<br />

to the company.<br />

Quantec uses its patented<br />

discovery of a novel milk<br />

protein to develop applications<br />

in human and animal health.<br />

Between them co-founders Dr<br />

Rod Claycomb and Dr Judy<br />

Bragger have many years’ experience<br />

in research and commercialisation<br />

in the dairy industry,<br />

both in New Zealand and overseas.<br />

One key existing investor<br />

(and investor director for<br />

SCIF) is Quantec chairman,<br />

John Birch, director of Perry<br />

Investment Management<br />

Limited and former chairman of<br />

Hamilton International Airport.<br />

“Quantec required funding<br />

for working capital to progress<br />

product safety trials, conclude<br />

subsidiary transactions to grow<br />

the Epiology and Quantec ingredients<br />

businesses and for further<br />

product development,” says Mr<br />

Birch.<br />

“Enterprise Angels worked<br />

with us to secure funding from<br />

SCIF, EA members, EA Fund<br />

2 and wholesale investors<br />

on AngelEquity. The exciting<br />

progress that we’ve made<br />

has helped us on our journey,<br />

including securing distribution<br />

of Quantec Ingredients products<br />

in China.”<br />

Also based out of the<br />

Quantec’s technical team from left, Dr Judy Bragger,<br />

Dr Colin Ogle and managing director Dr Rod Claycomb.<br />

developed a unique and powerful<br />

enzyme trademarked as<br />

Aloxsyn, which remediates<br />

damage from oxidation of fats<br />

in cell membranes. Chairman<br />

and major shareholder, Mark<br />

Backhaus, says the initial focus<br />

is on enhancing the survival and<br />

longevity of sperm from bulls<br />

used in the dairy industry and<br />

on improving the ability of cows<br />

delighted with the confidence<br />

in our company expressed by<br />

investors and the New Zealand<br />

Government following extensive<br />

due diligence.<br />

“We are particularly grateful<br />

for the encouragement and support<br />

that we have received from<br />

Enterprise Angels, Ice Angels<br />

and NZVIF. This new injection<br />

of capital allows us to accelerate<br />

Zealand, connecting experienced<br />

investors with entrepreneurs<br />

and innovators to assist<br />

them in obtaining funds as well<br />

as skills and expertise.<br />

A member of the Angel<br />

Association of New Zealand<br />

(AANZ), Enterprise Angels<br />

promotes and facilitates investor<br />

education by providing education<br />

events, active learning<br />

CUSTOMER<br />

AD ID<br />

WAIKATO TOYOTA<br />

AU-7515642AD (100%)<br />

PUBLISHING<br />

DESIGNER<br />

to conceive.<br />

our scientific and IP development<br />

programmes, as well as and best practice procedures.<br />

opportunities on actual deals<br />

18/01/17 SALES REP MANISH.KHETARPAL PUBLICATION PIAKO POST<br />

Innovation Park, Synthase “However, Aloxsyn is a<br />

OUTSOURCER Biotech has reached its maximum<br />

investment target, with be applied in many situations, “Synthase has had an excep-<br />

Enterprise Angels has facili-<br />

‘platform PROOFED technology’ 14/01/<strong>2017</strong> that 11:56:20 can our p.m. commercialisation effort. SIZE 26.2X18 Since launching in 2008,<br />

an injection of $800,000 in the<br />

start-up’s first capital raising<br />

outside of its founding group,<br />

including extension of shelf life<br />

in foods, providing longer storage<br />

of human organs and tissues<br />

tional 12 months, including<br />

winning a grant of $950,000<br />

from Callaghan Innovation and<br />

tated the investment of more<br />

than $22 million in 53 early<br />

stage and established businesses<br />

including funds from the New for transplantation, or biopsy, being listed as a finalist in the across a variety of industries,<br />

Synthase Biotechs’ team from left, executive director, Zealand Venture Investment and in human health itself,” he NZ Innovation Awards.” driving economic and business<br />

Andrew West, operations manager, Janine Cowling, senior Fund (NZVIF) and existing says.<br />

Tauranga-based Enterprise development within the Bay of<br />

scientist, Alex Hennebry, chief technical officer, Steve investors.<br />

Mr Backhaus says: Angels is a unique model of Plenty/<strong>Waikato</strong> region and New<br />

Hodgkinson and chairman, Mark Backhaus.<br />

Synthase Biotech has “Synthase Biotech Ltd is early-stage investing in New Zealand.<br />

PLEASE APPROVE THIS AD AS SOON AS POSSIBLE. NOTE THAT ANY ALTERATIONS MUST BE FINALISED BY OUR MATERIAL DEADLIN<br />

THE NEW HILUX<br />

TRD SPECIAL EDITION.<br />

AVAILABLE IN PRERUNNER OR 4X4.<br />

%<br />

GET 2.9 FINANCE *<br />

P.A.<br />

3YEARS SERVICING<br />

WARRANTY &AAROADSERVICE *<br />

FOR ALIMITED TIME ONLY, FROM<br />

$<br />

53,990 RSP*<br />

+ORC<br />

Available in 2WD PreRunner or 4WD, featuring an<br />

exclusive motorised hard lid with remote locking, and<br />

amatte black TRD honeycomb grille. Comes with<br />

nudge bar, TRD fender flares, sports bar, 18” Maxxis<br />

all terrain tyres on matte black TRD alloy wheels,<br />

anti-slip tray liner plus more. Visit toyota.co.nz or<br />

visit your local Toyota Dealer to secure yours.<br />

*Offer is available from 1<strong>January</strong> <strong>2017</strong> to 31 March <strong>2017</strong> (subject to stock availability) on any new <strong>2017</strong> Toyota Hilux<br />

TRD vehicle purchased from participating Authorised Toyota Dealers in New Zealand. 2.9% p.a. finance rate is only<br />

available *Offer is available on aClassic from 1<strong>January</strong> Finance <strong>2017</strong> to loan 31 March with<strong>2017</strong> aminimum (subject to stock of 20% availability) deposit on any for new terms <strong>2017</strong> Toyota up toHilux 36TRD months. vehicle purchased An establishment from fee<br />

ofparticipating up to $350 Authorised and a$15 Toyota PPSR Dealers in fee New are Zealand. payable. 2.9% p.a. Normal finance Toyota rate is only Financial available on Services a Classic Finance lending loan criteria with aminimum apply. of The 20% advertised<br />

deposit for terms up to 36 months. An establishment fee of up to $350 and a$15 PPSR fee arepayable. Normal Toyota Financial Services lending<br />

RSP’s are valid from 1<strong>January</strong> <strong>2017</strong> to 31 March <strong>2017</strong> only and are subject to change. The Service Plan covers parts<br />

criteria apply.The advertised RSP’s are valid from 1<strong>January</strong> <strong>2017</strong> to 31 March <strong>2017</strong> only and aresubject to change. The Service Plan covers parts<br />

and labour costs costs of scheduled of scheduled service items service for three items years/45,000km for three (whichever years /45,000km occurs first under (whichever normal operating occurs conditions). first under The Warranty normal operating<br />

conditions). provides cover The for three Warranty years /100,000km provides (whichever cover occurs for three first under years normal /100,000km operating conditions). (whichever For full occurs terms and first conditions under visit normal our operating<br />

website, www.toyota.co.nz<br />

conditions). For full terms and conditions visit our website, www.toyota.co.nz<br />

30253<br />

AU-7515642AD<br />

85 Avenue Road North, Morrinsville, 0800 828 696 | Vehicle Sales: Nick Thompson 027 205 6816 |Scott Grenside 021 508 766

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!